DC Devices secures another $34M for transcatheter cardiac shunt

Massachusetts-based DC Devices closed a $34 million Series D funding round in supports of its transcatheter InterAtrial Shunt Device.

Bay State startup DC Device announced the successful close of a $34 million Series D financing round, hoping to use the funds to advance clinical evaluation of its InterAtrial Shunt Device.

The company aims to market the world's 1st minimally invasive device for treating diastolic heart failure, a market worth a potential $5 billion globally, according to a DC Device press release.

DC Devices, General Catalyst, Lumira Capital, Third Rock Ventures LLC

News Well, Cardiac Implants, Funding Roundup, Venture Capital/Private Equity

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vw5aRd